Nifty
Sensex
:
:
11532.40
38363.47
70.20 (0.61%)
268.40 (0.70%)

Pharmaceuticals & Drugs

Rating :
68/99

BSE: 500420 | NSE: TORNTPHARM

1862.90
11.35 (0.61%)
19-Mar-2019 | 3:56PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  1853.85
  •  1885.00
  •  1853.05
  •  1851.55
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  166834
  •  3107.95
  •  1962.00
  •  1221.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 31,290.08
  • 38.35
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 36,885.14
  • 0.76%
  • 6.28

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 71.25%
  • 2.56%
  • 6.79%
  • FII
  • DII
  • Others
  • 0.11%
  • 9.98%
  • 9.31%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.88
  • 7.41
  • -3.64

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.89
  • 7.10
  • -13.25

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.91
  • 0.43
  • -26.86

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.52
  • 21.56
  • 25.62

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.55
  • 6.25
  • 5.71

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 12.38
  • 13.90
  • 14.69

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Net Sales
2,051.00
1,463.00
40.19%
1,894.00
1,417.00
33.66%
1,872.00
1,362.00
37.44%
1,722.00
1,434.00
20.08%
Expenses
1,490.00
1,104.00
34.96%
1,421.00
1,088.00
30.61%
1,395.00
1,065.00
30.99%
1,358.00
1,139.00
19.23%
EBITDA
561.00
359.00
56.27%
473.00
329.00
43.77%
477.00
297.00
60.61%
364.00
295.00
23.39%
EBIDTM
27.35%
24.54%
24.97%
23.22%
25.48%
21.81%
21.14%
20.57%
Other Income
3.00
74.00
-95.95%
10.00
78.00
-87.18%
27.00
105.00
-74.29%
42.00
104.00
-59.62%
Interest
133.00
80.00
66.25%
126.00
51.00
147.06%
122.00
56.00
117.86%
121.00
58.00
108.62%
Depreciation
156.00
94.00
65.96%
152.00
84.00
80.95%
150.00
80.00
87.50%
151.00
97.00
55.67%
PBT
275.00
259.00
6.18%
205.00
272.00
-24.63%
232.00
266.00
-12.78%
134.00
244.00
-45.08%
Tax
29.00
201.00
-85.57%
26.00
68.00
-61.76%
69.00
78.00
-11.54%
-94.00
38.00
-
PAT
246.00
58.00
324.14%
179.00
204.00
-12.25%
163.00
188.00
-13.30%
228.00
206.00
10.68%
PATM
11.99%
3.96%
9.45%
14.40%
8.71%
13.80%
13.24%
14.37%
EPS
14.54
3.43
323.91%
10.58
12.05
-12.20%
9.63
11.11
-13.32%
13.47
12.17
10.68%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Net Sales
7,539.00
5,982.26
5,815.69
6,686.93
4,653.45
4,184.72
3,211.14
2,695.92
2,197.79
1,916.04
1,630.66
Net Sales Growth
32.82%
2.86%
-13.03%
43.70%
11.20%
30.32%
19.11%
22.67%
14.70%
17.50%
 
Cost Of Goods Sold
2,149.00
1,535.17
1,629.66
1,452.21
1,280.96
1,107.58
807.98
774.38
616.64
516.71
487.56
Gross Profit
5,390.00
4,447.09
4,186.03
5,234.72
3,372.49
3,077.14
2,403.16
1,921.54
1,581.16
1,399.32
1,143.10
GP Margin
71.49%
74.34%
71.98%
78.28%
72.47%
73.53%
74.84%
71.28%
71.94%
73.03%
70.10%
Total Expenditure
5,664.00
4,641.21
4,438.42
3,957.13
3,633.29
3,233.24
2,518.92
2,203.54
1,810.01
1,495.26
1,371.93
Power & Fuel Cost
-
118.77
107.98
92.59
97.41
71.88
62.80
56.97
42.53
27.40
25.29
% Of Sales
-
1.99%
1.86%
1.38%
2.09%
1.72%
1.96%
2.11%
1.94%
1.43%
1.55%
Employee Cost
-
1,135.25
993.41
842.35
841.81
741.10
623.29
531.80
440.44
308.33
250.38
% Of Sales
-
18.98%
17.08%
12.60%
18.09%
17.71%
19.41%
19.73%
20.04%
16.09%
15.35%
Manufacturing Exp.
-
457.58
502.16
353.45
345.98
320.78
278.15
225.27
210.89
223.19
200.42
% Of Sales
-
7.65%
8.63%
5.29%
7.43%
7.67%
8.66%
8.36%
9.60%
11.65%
12.29%
General & Admin Exp.
-
718.38
578.05
637.92
477.59
399.07
324.55
255.89
206.88
177.67
150.91
% Of Sales
-
12.01%
9.94%
9.54%
10.26%
9.54%
10.11%
9.49%
9.41%
9.27%
9.25%
Selling & Distn. Exp.
-
633.06
567.70
547.05
574.40
461.53
393.07
322.29
274.61
225.10
197.36
% Of Sales
-
10.58%
9.76%
8.18%
12.34%
11.03%
12.24%
11.95%
12.49%
11.75%
12.10%
Miscellaneous Exp.
-
43.00
59.46
31.56
15.14
131.30
29.08
36.94
18.03
16.85
197.36
% Of Sales
-
0.72%
1.02%
0.47%
0.33%
3.14%
0.91%
1.37%
0.82%
0.88%
3.68%
EBITDA
1,875.00
1,341.05
1,377.27
2,729.80
1,020.16
951.48
692.22
492.38
387.78
420.78
258.73
EBITDA Margin
24.87%
22.42%
23.68%
40.82%
21.92%
22.74%
21.56%
18.26%
17.64%
21.96%
15.87%
Other Income
82.00
307.04
223.30
228.80
285.55
38.13
43.36
52.78
56.23
21.63
23.79
Interest
502.00
308.48
205.56
183.98
175.16
58.63
33.80
39.45
39.13
29.10
39.30
Depreciation
609.00
408.60
306.92
237.55
190.74
87.00
82.69
81.73
62.56
66.09
42.28
PBT
846.00
931.01
1,088.09
2,537.07
939.81
843.98
619.09
423.98
342.33
347.22
200.95
Tax
30.00
252.87
154.51
610.17
188.84
180.07
146.69
72.32
72.17
116.02
7.82
Tax Rate
3.55%
27.16%
14.20%
26.04%
20.09%
21.34%
25.22%
20.17%
21.08%
33.41%
4.07%
PAT
816.00
678.11
933.55
1,733.24
750.94
663.88
432.76
284.04
270.17
231.20
184.37
PAT before Minority Interest
816.00
678.14
933.58
1,733.27
750.97
663.91
434.91
286.30
270.17
231.20
184.37
Minority Interest
0.00
-0.03
-0.03
-0.03
-0.03
-0.03
-2.15
-2.26
0.00
0.00
0.00
PAT Margin
10.82%
11.34%
16.05%
25.92%
16.14%
15.86%
13.48%
10.54%
12.29%
12.07%
11.31%
PAT Growth
24.39%
-27.36%
-46.14%
130.81%
13.11%
53.41%
52.36%
5.13%
16.86%
25.40%
 
Unadjusted EPS
48.22
40.07
55.17
102.42
44.38
39.23
25.58
33.57
31.93
27.32
21.79

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Shareholder's Funds
4,622.19
4,350.13
3,494.10
2,490.56
1,902.43
1,421.93
1,193.83
1,022.40
830.98
650.89
Share Capital
84.62
84.62
84.62
84.62
84.62
42.31
42.31
42.31
42.31
42.31
Total Reserves
4,537.57
4,265.51
3,409.48
2,405.94
1,817.81
1,379.62
1,151.52
980.10
788.67
608.58
Non-Current Liabilities
4,142.42
2,303.33
1,994.65
2,504.92
926.76
619.81
487.73
397.60
572.29
541.00
Secured Loans
4,105.31
2,229.57
1,839.46
2,171.60
730.72
403.19
223.83
170.59
364.64
318.27
Unsecured Loans
6.15
11.26
10.62
13.62
13.74
51.35
98.22
122.45
157.75
164.33
Long Term Provisions
286.66
263.04
246.36
207.49
190.43
129.51
110.45
56.14
0.00
0.00
Current Liabilities
5,202.17
2,738.26
3,285.48
2,823.75
2,174.58
1,710.65
1,362.84
1,114.09
549.59
465.64
Trade Payables
2,048.24
1,749.32
2,260.22
1,827.72
1,429.13
1,067.74
863.47
615.00
383.60
313.41
Other Current Liabilities
1,151.68
687.14
822.28
446.15
371.63
275.83
291.00
312.85
43.39
60.90
Short Term Borrowings
1,625.60
0.00
3.32
319.07
210.43
124.62
138.12
99.57
0.00
0.00
Short Term Provisions
376.65
301.80
199.66
230.81
163.39
242.46
70.25
86.66
122.60
91.33
Total Liabilities
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76
3,047.90
2,535.69
1,952.86
1,657.53
Net Block
7,854.68
3,688.44
2,859.08
2,832.66
875.34
819.82
796.87
635.55
541.15
511.25
Gross Block
9,449.48
4,909.80
3,793.53
3,542.93
1,420.04
1,278.15
1,199.64
964.28
812.94
720.62
Accumulated Depreciation
1,594.80
1,221.36
934.45
710.27
544.70
458.33
402.77
328.73
271.79
209.37
Non Current Assets
8,704.89
4,512.74
4,085.66
3,768.25
1,599.69
1,191.87
1,060.78
941.27
670.02
583.72
Capital Work in Progress
646.94
519.49
1,041.58
678.33
534.11
285.28
113.55
179.88
109.82
53.42
Non Current Investment
0.09
0.09
0.09
0.06
0.03
0.03
37.52
20.00
19.05
19.05
Long Term Loans & Adv.
149.44
182.32
99.66
206.92
129.47
62.84
61.37
59.51
0.00
0.00
Other Non Current Assets
53.74
122.40
85.25
50.28
60.74
23.90
46.25
46.34
0.00
0.00
Current Assets
5,262.41
4,879.47
4,689.03
4,051.41
3,404.48
2,560.89
1,987.12
1,594.42
1,282.84
1,073.81
Current Investments
492.27
803.55
779.59
297.59
185.63
60.44
86.52
125.99
122.13
120.44
Inventories
1,966.30
1,559.15
1,357.98
1,067.17
1,006.06
923.86
531.56
504.83
323.63
264.54
Sundry Debtors
1,253.45
950.89
1,445.09
1,587.26
1,099.42
687.82
522.80
340.40
298.16
266.58
Cash & Bank
867.26
893.72
647.03
567.36
769.42
626.97
674.28
478.80
388.33
229.99
Other Current Assets
683.13
589.54
369.16
422.94
343.95
261.80
171.96
144.41
150.60
192.26
Short Term Loans & Adv.
96.24
82.62
90.18
109.09
84.95
75.95
56.46
49.28
109.06
157.94
Net Current Assets
60.24
2,141.21
1,403.55
1,227.66
1,229.90
850.24
624.28
480.33
733.26
608.17
Total Assets
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76
3,047.90
2,535.69
1,952.86
1,657.53

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
894.18
1,008.84
2,742.12
810.20
599.42
153.48
499.13
395.01
287.00
257.90
PBT
931.01
1,088.09
2,343.44
939.81
843.98
581.60
358.62
342.33
347.22
192.19
Adjustment
606.92
430.27
552.44
337.96
136.79
126.13
79.64
74.80
80.63
82.04
Changes in Working Capital
-360.13
-125.21
423.58
-409.38
-119.68
-421.75
143.58
61.88
-74.82
10.12
Cash after chg. in Working capital
1,177.80
1,393.15
3,319.46
868.39
861.09
285.98
581.84
479.01
353.04
284.34
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-283.62
-384.31
-577.34
-58.19
-261.67
-132.50
-82.71
-84.00
-66.04
-26.44
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-4,706.95
-786.91
-837.85
-2,162.30
-355.81
-241.70
-136.97
-232.60
-128.71
-39.58
Net Fixed Assets
-4,245.22
-592.01
-471.42
-2,266.57
-308.01
-455.28
-84.67
-52.13
-152.17
-34.10
Net Investments
310.79
-17.69
-484.32
-111.97
-131.60
287.55
-47.29
-199.04
13.48
-86.91
Others
-772.52
-177.21
117.89
216.24
83.80
-73.97
-5.01
18.57
9.98
81.43
Cash from Financing Activity
3,417.39
-192.91
-1,435.15
1,212.25
86.40
19.73
-192.74
-67.61
-5.25
-18.23
Net Cash Inflow / Outflow
-395.38
29.02
469.12
-139.85
330.01
-68.49
169.42
94.80
153.05
200.09
Opening Cash & Equivalents
1,067.57
1,049.86
612.38
955.05
687.41
760.80
604.79
510.45
350.43
153.84
Closing Cash & Equivalent
702.07
1,067.57
1,049.86
864.95
955.05
687.41
760.80
604.79
510.45
350.43

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
273.11
257.04
206.46
147.16
112.41
84.02
70.54
60.42
49.11
38.46
ROA
5.81%
10.28%
20.89%
11.71%
15.16%
12.79%
10.26%
12.04%
12.81%
12.61%
ROE
15.12%
23.80%
57.92%
34.19%
39.94%
33.25%
25.84%
29.15%
31.20%
31.78%
ROCE
13.81%
20.36%
45.63%
26.98%
35.06%
31.66%
23.65%
25.88%
30.26%
23.12%
Fixed Asset Turnover
0.84
1.35
1.82
1.88
3.11
2.60
2.50
2.48
2.54
2.43
Receivable days
67.03
74.66
82.76
105.19
77.81
68.65
58.33
52.95
52.84
52.49
Inventory Days
107.20
90.90
66.19
81.17
84.02
82.53
70.03
68.69
55.03
54.44
Payable days
151.26
171.27
204.35
176.11
158.58
143.69
136.22
103.96
90.60
83.99
Cash Conversion Cycle
22.96
-5.72
-55.41
10.25
3.25
7.50
-7.86
17.68
17.27
22.94
Total Debt/Equity
1.40
0.58
0.67
1.10
0.59
0.49
0.48
0.56
0.63
0.74
Interest Cover
4.02
6.29
13.74
6.37
15.40
18.21
10.09
9.75
12.93
5.89

News Update:


  • Torrent Pharma recalls 2.30 lakh bottles of high BP treatment tablets from US
    1st Mar 2019, 10:35 AM

    The tablets were manufactured by Torrent Pharma in its Mehsana facility in India

    Read More
  • Torrent Pharma - Quarterly Results
    30th Jan 2019, 16:19 PM

    Read More
  • Torrent Pharma recalls 16 batches of losartan potassium tablets from US
    24th Jan 2019, 10:22 AM

    The company is recalling the tablets due to an unexpected impurity found in an API

    Read More
  • Torrent group to invest Rs 10,000 crore in Gujarat
    19th Jan 2019, 12:58 PM

    The group has already invested Rs 30,000 crore in the state in power and pharmaceutical sectors

    Read More
  • Torrent Pharmaceuticals redeems NCDs worth Rs 166.65 crore
    31st Dec 2018, 12:00 PM

    The company has repaid the same on December 28, 2018

    Read More
  • Torrent Pharma recalls two lots of Losartan potassium tablets from US market
    21st Dec 2018, 11:43 AM

    The recall is due to detection of traces of unexpected impurity

    Read More
  • Torrent Pharmaceuticals redeems NCDs worth Rs 100 crore
    14th Dec 2018, 10:41 AM

    The company has repaid the same on December 13, 2018

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.